methionine has been researched along with Hallucinations in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, J; Heron, J; Lewis, G; Owen, MJ; Zammit, S | 1 |
| Kety, SS | 1 |
| Cohen, SM; Nichols, A; Pollin, W; Wyatt, R | 1 |
1 review(s) available for methionine and Hallucinations
| Article | Year |
|---|---|
The administration of methionine to chronic schizophrenic patients: a review of ten studies.
Topics: Adult; Brain Chemistry; Chronic Disease; Delusions; Emotions; Female; Hallucinations; Humans; Male; Methionine; Middle Aged; Models, Biological; Monoamine Oxidase Inhibitors; Perception; Psychoses, Substance-Induced; Research Design; Schizophrenia; Schizophrenic Psychology; Serotonin | 1974 |
2 other study(ies) available for methionine and Hallucinations
| Article | Year |
|---|---|
Cannabis, COMT and psychotic experiences.
Topics: Adolescent; Catechol O-Methyltransferase; Child; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Genotype; Hallucinations; Haplotypes; Humans; Longitudinal Studies; Male; Marijuana Abuse; Methionine; Polymorphism, Single Nucleotide; Psychotic Disorders; Risk; Self Report; Valine | 2011 |
Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
Topics: Amphetamine; Antipsychotic Agents; Brain; Butyrophenones; Disease Susceptibility; Dopamine; Dopamine beta-Hydroxylase; Hallucinations; Hallucinogens; Humans; Methionine; Methylation; Norepinephrine; Phenothiazines; Psychoses, Substance-Induced; Receptors, Drug; Schizophrenia; Structure-Activity Relationship | 1972 |